Eczacıbaşı-Monrol Nuclear Products, which was established in 2008 as an equal joint venture between Bozlu Holding and Eczacıbaşı Pharmaceuticals Manufacturing and as 2017 Eczacıbaşı Pharmaceuticals Manufacturing has the major share, leads the development of Turkey’s nuclear medicine market through the production of high-quality radiopharmaceuticals for diagnosis and treatment. 

 

Eczacıbaşı-Monrol has 10 world-class production facilities, 6 in Turkey and 4 abroad, employing modern and environment-friendly technologies.  The company also has been operating cyclotrons in Kuwait and United Arab Emirates.

 

Eczacıbaşı-Monrol whose headquarters is located in Ataşehir, has been serving with its 300 employees and 15 distributors to supply nuclear medicine centers in Turkey and more than 30 countries around the world without compromising on quality and customer-oriented service.